NCT00147511已完成4 期
Time To Efficacy and Onset Of Action Of Linezolid In Skin and Soft Tissue Infections
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 118
- 主要终点
- Time to defervescence
研究概览
简要总结
To assess the onset of action of linezolid
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •suspected grampositive infection
- •fever > 38 C
排除标准
- •Infections to be treated successfully by surgical procedures
结局指标
主要结局
Time to defervescence
次要结局
- Reduction of CRP levels Reduction of leucocyte count
研究者
相似试验
已完成
1 期
Linezolid Pharmacokinetics (PK) in Multi-Drug Resistant (MDR)/Extensively-Drug Resistant (XDR) Tuberculosis (TB)Multi-Drug Resistant TuberculosisExtensively Drug Resistant TuberculosisNCT00691392Centers for Disease Control and Prevention26
已完成
4 期
Linezolid for Treatment of Nontuberculous Mycobacterial DiseasesNon-tuberculous Mycobacterial InfectionsNCT03220074Mahidol University40
招募中
不适用
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant TuberculosisRifampin-resistant TuberculosisDrug-resistant TuberculosisNCT06590428Albert Einstein College of Medicine280
已完成
3 期
Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDRTuberculosisExtensively Drug-Resistant TuberculosisPre-XDR-TBXDR-TBNCT03086486Global Alliance for TB Drug Development181
已完成
2 期
Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndromeIRCT20141008019464N2Kerman University of Medical Sciences40